We are very excited about the launch of Biotix Plus®, which will be available in select Walgreens stores beginning this summer.
Costa Mesa, CA (PRWEB) July 03, 2017
U.S. Doctors’ Clinical® is excited to announce today that it has received the first order of Biotix Plus® synergistic probiotic dietary supplement from Walgreens, and expects to begin shipping on July 3, 2017.
“We are very excited about the launch of Biotix Plus®, which will be available in select Walgreens stores beginning this summer. This marks a major milestone in the development and growth of the U.S. Doctors’ Clinical® brand. By adding a new probiotic supplement and significantly expanding distribution within Walgreens store footprint, we expect significant revenue and earnings growth in the coming quarters," said Tom Nguyen, CEO and Founder of the U.S. Doctors’ Clinical® brand.
Digestive issues continue to be a major source of discomfort and inconvenience for a large number of individuals. Biotix Plus® delivers 24/7 digestive support, intestinal protection against harmful bacteria, and supports immune system function with a combination of clinically studied, trademarked prebiotic and probiotic strains. These clinically studied ingredients work synergistically to build up the good bacteria in your intestines and colon, where you really need it – pushing out bad bacteria, helping the body digest food properly, aiding in nutrient absorption and even toxin disposal.
Biotix Plus® is available in high absorption, easy-to-swallow softgels that are shelf-stable for up to two years and require NO refrigeration. Walgreens will carry the 60-count bottle at the suggested retail price of $39.99 per unit.
U.S. Doctors’ Clinical® products are also available at Rite Aid, Kmart, Wegmans Food Market, and other online retailers. For more information, please visit http://www.usdoctorsclinical.com.
About U.S. Doctors’ Clinical®
U.S. Doctors’ Clinical® is a premium supplement line that features both doctor-recommend and doctor-formulated products for a range of health areas. Each product contains high-quality nutrients that delivers maximum purity and effectiveness, and made to the standards of professional doctors and healthcare practitioners. All USDC products have undergone rigorous testing with results featured in numerous prestigious journals and publications.
U.S. Doctors’ Clinical® additionally features supplements in several delivery forms for customer preference and convenience, including highly absorbable softgels, capsules, and tablets, as well as a specialty vegetarian softgels line that contain no animal sources, are non-gmo, gluten-free, and are appropriate for vegans. All products are produced by a USA-based manufacturer that is fully-certified for several third-party certifications (NPA, NFS, UL and CCOF) upholds cGMP practices, and uses the latest in advanced supplement technology.
See the Company's web site at http://www.usdoctorsclinical.com for additional product information or email Public_Relations(at)usdoctorsclinical(dot)com.
About Our New Retail Partner
Walgreens (http://www.walgreens.com), one of the nation's largest drugstore chains, is included in the Retail Pharmacy USA Division of Walgreens Boots Alliance, Inc., the first global pharmacy-led, health and wellbeing enterprise. More than 10 million customers interact with Walgreens each day in communities across America, using the most convenient, multichannel access to consumer goods and services and trusted, cost-effective pharmacy, health and wellness services and advice. Walgreens operates 8,175 drugstores with a presence in all 50 states, the District of Columbia, Puerto Rico and the U.S. Virgin Islands, along with its omnichannel business, Walgreens.com. Approximately 400 Walgreens stores offer Healthcare Clinic or other provider retail clinic services. For more information on Walgreens, visit http://www.walgreens.com.
Forward Looking Statements
This press release includes statements, which may constitute forward looking statements made pursuant to the safe harbor provision of the Private Securities Litigation Reform Act of 1995. These statements are subject to risks and uncertainties that could cause actual results to differ materially from the forward-looking statements. Factors which would cause or contribute to such differences include, but are not limited to competition from existing or new products, production delays, lack of market acceptance of the Company's products, the Company's ability to develop acceptable sales and marketing relationships, the Company's ability to generate necessary capital, and general economic conditions and such other factors as are detailed in the Company's Securities and Exchange Commission filings.
- These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.
- Biotix Plus is a registered trademark of U.S. Doctors’ Clinical. All rights reserved